XM does not provide services to residents of the United States of America.

Downbeat start for stocks on ECB day



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>LIVE MARKETS-Downbeat start for stocks on ECB day</title></head><body>

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.


DOWNBEAT START FOR STOCKS ON ECB DAY

European shares were set to fall at the open on Thursday on a busy day for earnings and corporate news, with the European Central Bank meeting setting the overall tone.

Euro Stoxx 50 futures were down 0.45% with U.S. share futures also down, but, the broad STOXX 600 benhcmark did hit a fresh all time high on Wednesday.

In earnings and company news there is plenty happening.

Lufthansa, LHAG.DE alongside reporting in line operating profits, adjusted its outlook for its 2024 operating margin down to 7.6% from a goal of 8% as it struggles with labour disputes, and pharma giant Merck MRCG.DE forecast a return to modest operating earnings growth this year when adjusted for currency headwinds.

In UK finance news, Nationwide Building Society NBS.L has agreed to buy lender Virgin Money UK VMUK.L for around 2.9 billion pounds ($3.69 billion), the companies said on Thursday, in an all-cash deal set to create a new rival to Britain's biggest banks.

Elsewhere in the world of deals, German rail operator Deutsche Bahn expects at least 10 biddersto submit offers for its logistics subsidiary Schenker and aims to sign a contract for the sale in the second half of 2024, two people familiar with the matter told Reuters on Wednesday.

As for the big picture, the European Central Bank is set to keep interest rates at record highs on Thursday and take baby steps towards cutting them in the coming months as inflation continues to fall despite stubbornly high underlying price pressures.


(Alun John)



MORNING BID EUROPE- ECB ALSO WANTS MORE EVIDENCE

Federal Reserve Chair Jerome Powell was unambiguous overnight, but the European Central Bank meets today and is more divided and hesitant about committing to monetary easing.

The ECB is universally expected to keep its policy rate at a record 4.0%, and policymakers are likely to repeat that they need more evidence inflation is under control and that ongoing wage increases will not give it another leg up.

ECB President Christine Lagarde's message will be key, for new economic projections are likely to point to lower economic growth and inflation this year, which may require the central bank to tweak its message slightly.

Investors have pencilled in three or probably four rate cuts by the end of the year 0#ECBWATCH.

Interest rate futures are almost fully priced in for a first rate cut from the ECB in June, with a total easing of 88 basis points expected for all of this year. That's more realistic than the 150 bps markets were expecting in January.

German data on factory orders and production is due later, and should reinforce the weakness in the euro zone's largest economy and the reason the ECB is so divided.

Meanwhile, Asia is extending the broad rally in global stocks and risk assets after Powell kept the door open to interest rate cuts later this year and U.S. bond yields drifted lower

Powell stuck to script by saying the Fed still expects to cut rates later this year, even though continued progress on inflation "is not assured".

Japan's Nikkei .N225, however, is down as the yen jumps to near 149 per dollar, its highest in a month, as momentum builds that a move from the Bank of Japan to end negative interest rates could come as soon as this month.

Key developments that could influence markets on Thursday:

CENTRAL BANKS-ECB rate decision at 1315 GMT, Lagarde press conference at 1345 GMT

DATA - German industrial orders, UK Halifax house prices

DEBT AUCTIONS - France: Reopening of 10-year 2033, 10-year 2034, 14-year and 21-year government debt auctions

EARNINGS - Admiral Group, Continental AG, Deutsche Lufthansa AG, Hugo Boss AG, ITV PLC, Merck KGaA


(Vidya Ranganathan)


</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.